Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of AJU-C714 vs C714R in Healthy Volunteers
NCT06933459Phase 1Active, not recruiting
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- May 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AJU-C714 in dyslipidemia (2 arms), sponsored by AJU PHARM Co., Ltd. Primary endpoints: Area Under the Concentration-time Curve from time zero to the last measurable concentration at 72 hours and Maximum Plasma Concentration at 72 hours. Started May 2025; status: active, not recruiting.
02
Drugs
AJU-C714
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT06933459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06933459.